Eli Lilly stock forecast 2025 aligns with high call-buying activity on $900 strike contracts. Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. Now, the share price is 14.0% lower than six months ago, despite an 19.5% pop in the past month after positive Phase 3 results for its experimental oral weight-loss drug and the launch of its Brain Health Matters campaign. The question for investors is whether the latest move is more of the year’s ongoing volatility or the stock has begun a sustained run higher. What will Lilly stock do in the next three to five years, and beyond? 24/7 Wall St. looks at projected revenue and net income to give you our best estimate of future stock prices from 2025 to 2030. Analysts in Q2 2024 noted that Eli Lilly stock forecast 2025 could see share prices averaging between $850–$900, assuming revenue growth sustains at 18% CAGR. Institutional accumulation remains high, reflecting confidence in long-term biopharma expansion.